Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-08

Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), Versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate Mofetil in Kidney Transplant Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing extended-release tacrolimus plus sirolimus to extended-release tacrolimus plus mycophenolate mofetil in kidney transplant pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Advagraf (tacrolimus)
  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
  • Rapamune (sirolimus)

Snippet

Sponsor: Yonsei University | Conditions: Kidney Transplant Patients | Phase 4 | Status: COMPLETED